Elixinol Global to present at leading European industry conferences

Elixinol Global Limited (EXL or the Company) (ASX:EXL; OTCQX:ELLXF), a global company operating in the hemp, CBD dietary supplements and emerging medicinal cannabis sectors, is pleased to announce CEO Paul Benhaim will be presenting on the topic of “Cannabis in a modern and changing world” at the following major European Industry Conferences in June:

16th EIHA Hemp Conference
When: 5 June, 2019
Where: Maternushaus, Kardinal Frings Straße 1-3, 50668 Köln (Cologne), Germany
Website: http://eiha-conference.org

Irish Industrial Hemp Summit
When: 20 June, 2019
Where: Teagasc National Food Centre, Ashtown, Dublin


About Elixinol Global Limited Limited (ASX:EXL; OTCQX:ELLXF)
Elixinol Global through its businesses has a global presence in the cannabis industry including hemp-derived CBD dietary supplements, hemp food and wellness products, as well as cultivation and manufacture of medicinal cannabis products. EXL’s businesses include:

  • Elixinol LLC (“Elixinol”), founded in 2014, is a manufacturer and global distributor of hemp dietary supplement and skincare products, with operations based out of Colorado, USA.
  • Hemp Foods Australia Pty Ltd (“Hemp Foods Australia”), founded in 1999, is a leading hemp food wholesaler, retailer, manufacturer and exporter of bulk and branded raw materials, and finished products.
  • Nunyara Pharma Pty Ltd (“Nunyara”), formerly known as Elixinol Australia, was founded in 2014 to participate in the emerging Australian medicinal cannabis market and submitted licence applications for cultivation and manufacture to the Office of Drug Control in early 2018. These applications are currently pending approval.

Register Interest